2022 |
Stoicescu, C., Lataire, Q., Peters, K., Amon, J. J., Kamarulzaman, A., Ali, R., . . . Cepeda, J. (2022). End compulsory drug treatment in the Asia-Pacific region. The Lancet, 399(10323), 419-421. DOI |
2022 |
Zahra, E., Chen, R., Nielsen, S., Tran, A. D., Santo, T., Degenhardt, L., . . . Larance, B. (2022). Examining the cost and impact of dosing fees among clients in opioid agonist treatment: results from a cross-sectional survey of Australian treatment clients. Drug and Alcohol Review, 41(4), 841-850. DOI |
2022 |
Conigrave, J. H., Wilson, S., Conigrave, K. M., Chikritzhs, T., Hayman, N., Dawson, A., . . . Lee, K. S. K. (2022). ‘The Drug Survey App’: a protocol for developing and validating an interactive population survey tool for drug use among Aboriginal and Torres Strait Islander Australians. Addiction Science and Clinical Practice, 17(1), 11 pages. DOI |
2022 |
Jones, N. R., Hickman, M., Nielsen, S., Larney, S., Dobbins, T., Ali, R., & Degenhardt, L. (2022). The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: Findings from the OATS retrospective linkage study. . Drug and alcohol dependence, 236, 109464. DOI |
2022 |
Farrell, M., Shahbazi, J., Byrne, M., Grebely, J., Lintzeris, N., Chambers, M., . . . Degenhardt, L. (2022). Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence. International Journal of Drug Policy, 100, 103492. DOI |
2021 |
Conigrave, K. M., Ali, R. L., Armstrong, R., Chikritzhs, T. N., d'Abbs, P., Harris, M. F., . . . Banks, E. (2021). Revision of the Australian guidelines to reduce health risks from drinking alcohol. Medical Journal of Australia, 215(11), 518-524. DOI Scopus1 Europe PMC1 |
2021 |
Vuong, T., Ritter, A., Shanahan, M., Ali, R., Nguyen, N., & Minh, K. P. (2021). Quality of life as a predictor of time to heroin relapse among male residents following release from compulsory rehabilitation centres in Vietnam. Drug and Alcohol Review, 40(2), 296-306. DOI Scopus1 WoS1 Europe PMC1 |
2021 |
Nielsen, S., Sanfilippo, P., Belackova, V., Day, C., Silins, E., Lintzeris, N., . . . Larance, B. (2021). Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: Findings from a cross-sectional study in three Australian cities. Addiction, 116(6), 1482-1494. DOI Scopus1 WoS1 |
2021 |
Jones, N. R., Hickman, M., Larney, S., Nielsen, S., Ali, R., Murphy, T., . . . Degenhardt, L. (2021). Hospitalisations for non-fatal overdose among people with a history of opioid dependence in New South Wales, Australia, 2001-2018: findings from the OATS retrospective cohort study. Drug and Alcohol Dependence, 218, 108354-1-108354-10. DOI Scopus1 |
2021 |
Jones, N. R., Nielsen, S., Farrell, M., Ali, R., Gill, A., Larney, S., & Degenhardt, L. (2021). Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001-2018: Implications for treatment systems and potential impact on client outcomes. Drug Alcohol Depend, 219, 1-8. DOI Scopus4 WoS2 |
2021 |
Bharat, C., Larney, S., Barbieri, S., Dobbins, T., Jones, N. R., Hickman, M., . . . Degenhardt, L. (2021). The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study. Addiction (Abingdon, England), 116(11), 3139-3152. DOI Scopus5 WoS2 |
2021 |
Siefried, K. J., Ezard, N., Christmass, M., Haber, P., Ali, R., & The Nccred Methamphetamine And Emerging Drugs Clinical Research Network Working Group. (2021). A clinical research priority setting study for issues related to the use of methamphetamine and emerging drugs of concern in Australia.. Drug and alcohol review, 41(2), 11 pages. DOI Scopus1 WoS1 |
2020 |
Larney, S., Jones, N., Fiellin, D. A., Nielsen, S., Hickman, M., Dobbins, T., . . . Degenhardt, L. (2020). Data resource profile: the Opioid Agonist Treatment and Safety (OATS) Study, New South Wales, Australia. International Journal of Epidemiology, 49(6), 1774-1775g. DOI Scopus3 WoS2 Europe PMC1 |
2020 |
Larance, B., Degenhardt, L., Grebely, J., Nielsen, S., Bruno, R., Dietze, P., . . . Farrell, M. (2020). Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia. Addiction, 115(7), 1295-1305. DOI Scopus26 WoS26 Europe PMC13 |
2020 |
Jin, H., Larney, S., Marshall, B. D. L., Degenhardt, L., Strang, J., Hickman, M., . . . Bruneau, J. (2020). Global opioid agonist treatment: a review of clinical practices by country. Addiction, 115(12), 2243-2254. DOI Scopus20 WoS22 Europe PMC8 |
2020 |
Larance, B., Byrne, M., Lintzeris, N., Nielsen, S., Grebely, J., Degenhardt, L., . . . CoLAB study team. (2020). Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study.. BMJ Open, 10(7), e034389. DOI Scopus5 WoS5 Europe PMC2 |
2020 |
McKetin, R., Boden, J. M., Foulds, J. A., Najman, J. M., Ali, R., Degenhardt, L., . . . Weatherburn, D. (2020). The contribution of methamphetamine use to crime: evidence from Australian longitudinal data. Drug and Alcohol Dependence, 216, 108262-1-108262-6. DOI Scopus5 WoS4 |
2019 |
Farrell, M., Martin, N. K., Stockings, E., Bórquez, A., Cepeda, J. A., Degenhardt, L., . . . McKetin, R. (2019). Responding to global stimulant use: challenges and opportunities. The Lancet, 394(10209), 1652-1667. DOI Scopus75 WoS77 Europe PMC27 |
2019 |
Marsden, J., Tai, B., Ali, R., Hu, L., Rush, A. J., & Volkow, N. (2019). Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective?. Addiction, 114(8), 1346-1353. DOI Scopus24 WoS23 Europe PMC12 |
2019 |
Kalayasiri, R., Rungnirundorn, T., Ali, R., & Marsden, J. (2019). Regulation and decriminalisation of illegal substances in Thailand. Journal of Health Science and Medical Research, 37(2), 157-162. DOI |
2019 |
Marsden, J., Tai, B., Ali, R., Hu, L., Rush, A. J., & Volkow, N. D. (2019). Response to commentaries. Addiction, 114(8), 1357-1358. DOI |
2018 |
Ali, R., & Mcketin, R. (2018). Latent psychotic symptom profiles amongst people who use methamphetamine: what do they tell us about existing diagnostic categories?. Frontiers in Psychiatry, 9, 1-8. DOI Scopus6 WoS6 Europe PMC3 |
2018 |
Ezard, N., Dunlop, A., Hall, M., Ali, R., McKetin, R., Bruno, R., . . . Lintzeris, N. (2018). LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence. BMJ Open, 8(7), e020723. DOI Scopus10 WoS8 Europe PMC6 |
2018 |
Larney, S., Hickman, M., Fiellin, D. A., Dobbins, T., Nielsen, S., Jones, N. R., . . . Degenhardt, L. (2018). Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study. BMJ Open, 8(8), e025204-1-e025204-6. DOI Scopus13 WoS14 Europe PMC6 |
2018 |
Webster, S., Robinson, S., Ali, R., & Marsden, J. (2018). Improving outcomes in the treatment of opioid dependence (IOTOD): reflections on the impact of a medical education initiative on healthcare professionals' attitudes and clinical practice. Journal of European CME, 7(1), 1-8. DOI |
2018 |
Newcombe, D., Humeniuk, R., Dennington, V., & Ali, R. (2018). Participant perspectives on the Australian WHO ASSIST Phase III brief intervention for illicit drug use in a primary healthcare setting. Australian Journal of Primary Health, 24(6), 518-523. DOI |
2018 |
Vuong, T., Ritter, A., Shanahan, M., Ali, R., Nguyen, N., Pham, K., . . . Le, G. (2018). Outcomes of compulsory detention compared to community-based voluntary methadone maintenance treatment in Vietnam. Journal of Substance Abuse Treatment, 87, 9-15. DOI Scopus9 WoS8 Europe PMC3 |
2018 |
Humeniuk, R., Newcombe, D., Dennington, V., & Ali, R. (2018). A randomised controlled trial of a brief intervention for illicit drug use linked to ASSIST screening in a primary healthcare setting: results from the Australian component of the World Health Organization Phase III ASSIST studies. Australian Journal of Primary Health, 24(2), 149-154. DOI Scopus4 WoS3 Europe PMC1 |
2018 |
Peacock, A., Leung, J., Larney, S., Colledge, S., Hickman, M., Rehm, J., . . . Degenhardt, L. (2018). Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction, 113(10), 1905-1926. DOI Scopus348 WoS343 Europe PMC167 |
2018 |
Lintzeris, N., Monds, L., Rivas, C., Leung, S., Dunlop, A., Newcombe, D., . . . Ali, R. (2018). Transferring Patients from Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines. Journal of Addiction Medicine, 12(3), 234-240. DOI Scopus13 WoS12 Europe PMC6 |
2018 |
Larance, B., Dobbins, T., Peacock, A., Ali, R., Bruno, R., Lintzeris, N., . . . Degenhardt, L. (2018). The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study. The Lancet Psychiatry, 5(2), 155-166. DOI Scopus25 WoS21 Europe PMC10 |
2017 |
Vuong, T., Ritter, A., Nguyen, N., & Ali, R. (2017). Strengthening advocacy efforts with empirical evidence: a case example of the conduct, uptake and utilisation of research in drug policy decision-making in Vietnam. International Journal of Drug Policy, 49, 41-47. DOI |
2017 |
Gowing, L., Ali, R., & White, J. (2017). Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database of Systematic Reviews, 2017(5), 55 pages. DOI Scopus32 WoS11 Europe PMC11 |
2017 |
Xiaolu, R., Wenwen, W., Ali, R., Xu, L., Hong, W., Min, Z., & Jiang, D. (2017). Feasibility of studying a brief intervention to help Chinese villagers with problem alcohol use after an earthquake. Alcohol and Alcoholism, 52(4), 472-476. DOI Scopus5 WoS3 Europe PMC3 |
2017 |
Gowing, L., Ali, R., White, J., & Mbewe, D. (2017). Buprenorphine for managing opioid withdrawal. Cochrane Database of Systematic Reviews, 2017(2), 1-95. DOI Scopus92 WoS74 Europe PMC33 |
2017 |
Vuong, T., Nguyen, N., Le, G., Shanahan, M., Ali, R., & Ritter, A. (2017). The political and scientific challenges in evaluating compulsory drug treatment centers in Southeast Asia. Harm Reduction Journal, 14(1), 2-1-2-14. DOI Scopus13 WoS14 Europe PMC4 |
2017 |
Schwartz, R., McNeely, J., Wu, L., Sharma, G., Wahle, A., Cushing, C., . . . Subramaniam, G. (2017). Identifying substance misuse in primary care: TAPS Tool compared to the WHO ASSIST. Journal of Substance Abuse Treatment, 76, 69-76. DOI Scopus7 WoS6 Europe PMC6 |
2016 |
Peacock, A., Bruno, R., Larance, B., Lintzeris, N., Nielsen, S., Ali, R., . . . Degenhardt, L. (2016). Same-day use of opioids and other central nervous system depressants amongst people who tamper with pharmaceutical opioids: a retrospective 7-day diary study. Drug and Alcohol Dependence, 166, 125-133. DOI Scopus8 WoS7 Europe PMC2 |
2016 |
Hotham, E. D., Ali, R. L., White, J. M., & Robinson, J. S. (2016). Ethical considerations when researching with pregnant substance users and implications for practice. Addictive Behaviors, 60, 242-243. DOI Scopus3 WoS2 Europe PMC1 |
2016 |
Vuong, T., Shanahan, M., Nguyen, N., Le, G., Ali, R., Pham, K., . . . Ritter, A. (2016). Cost-effectiveness of center-based compulsory rehabilitation compared to community-based voluntary methadone maintenance treatment in Hai Phong City, Vietnam. Drug and Alcohol Dependence, 168, 147-155. DOI Scopus20 WoS17 Europe PMC10 |
2016 |
McKetin, R., Gardner, J., Baker, A., Dawe, S., Ali, R., Voce, A., . . . Lubman, D. (2016). Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users. Psychiatry Research, 238, 166-171. DOI Scopus24 WoS24 Europe PMC14 |
2016 |
White, N., Ali, R., Larance, B., Zador, D., Mattick, R. P., & Degenhardt, L. (2016). The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine-naloxone film. Drug and Alcohol Review, 35(1), 76-82. DOI Scopus15 WoS15 Europe PMC1 |
2016 |
Hotham, E., Ali, R., & White, J. (2016). Analysis of qualitative data from the investigation study in pregnancy of the ASSIST Version 3.0 (the Alcohol, Smoking and Substance Involvement Screening Test). Midwifery, 34, 183-197. DOI Scopus7 WoS7 |
2016 |
Gowing, L., Farrell, M., Ali, R., & White, J. (2016). Alpha2-adrenergic agonists for the management of opioid withdrawal. Cochrane Database of Systematic Reviews, 2016(5), 88 pages. DOI Scopus76 WoS87 Europe PMC25 |
2016 |
Larance, B., Mattick, R., Ali, R., Lintzeris, N., Jenkinson, R., White, N., . . . Degenhardt, L. (2016). Diversion and injection of buprenorphine-naloxone film two years post-introduction in Australia. Drug and Alcohol Review, 35(1), 83-91. DOI Scopus11 WoS11 Europe PMC2 |
2015 |
Peacock, A., Degenhardt, L., Larance, B., Cama, E., Lintzeris, N., Ali, R., & Bruno, R. (2015). A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone. Pharmacoepidemiology and Drug Safety, 24(12), 1321-1333. DOI Scopus5 WoS4 |
2015 |
Larance, B., Lintzeris, N., Bruno, R., Peacock, A., Cama, E., Ali, R., . . . Degenhardt, L. (2015). The characteristics of a cohort who tamper with prescribed and diverted opioid medications. Journal of Substance Abuse Treatment, 58, 51-61. DOI Scopus18 WoS18 Europe PMC10 |
2015 |
Larance, B., Dietze, P., Ali, R., Lintzeris, N., White, N., Jenkinson, R., & Degenhardt, L. (2015). The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: uptake and issues arising from changing buprenorphine formulations. Drug and Alcohol Review, 34(6), 603-610. DOI Scopus7 WoS7 Europe PMC3 |
2015 |
Degenhardt, L., Larance, B., Bruno, R., Lintzeris, N., Ali, R., & Farrell, M. (2015). Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol. Addiction, 110(2), 226-237. DOI Scopus17 WoS18 Europe PMC10 |
2015 |
Peacock, A., Bruno, R., Cama, E., Kihas, I., Larance, B., Lintzeris, N., . . . Degenhardt, L. (2015). Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids. Drug and Alcohol Review, 34(6), 611-622. DOI Scopus12 WoS10 Europe PMC5 |
2015 |
White, N., Flaherty, I., Higgs, P., Larance, B., Nielsen, S., Degenhardt, L., . . . Lintzeris, N. (2015). Injecting buprenorphine-naloxone film: findings from an explorative qualitative study. Drug and Alcohol Review, 34(6), 623-629. DOI Scopus5 WoS3 Europe PMC3 |
2015 |
Gowing, L., Ali, R., Allsop, S., Marsden, J., Turf, E., West, R., & Witton, J. (2015). Global statistics on addictive behaviours: 2014 status report. Addiction, 110(6), 904-919. DOI Scopus241 WoS217 Europe PMC122 |
2015 |
Degenhardt, L., Bruno, R., Ali, R., Lintzeris, N., Farrell, M., & Larance, B. (2015). The introduction of a potentially abuse deterrent oxycodone formulation: early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study. Drug and Alcohol Dependence, 151(.), 56-67. DOI Scopus28 WoS28 Europe PMC17 |
2015 |
Tanguay, P., Kamarulzaman, A., Aramrattana, A., Wodak, A., Thomson, N., Ali, R., . . . Chabungbam, A. (2015). Facilitating a transition from compulsory detention of people who use drugs towards voluntary community-based drug dependence treatment and support services in Asia. Harm Reduction Journal, 12(1), 5 pages. DOI Scopus20 WoS20 Europe PMC9 |
2014 |
Larance, B., Carragher, N., Mattick, R., Lintzeris, N., Ali, R., & Degenhardt, L. (2014). A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: do stable patients receive more unsupervised doses?. Drug and Alcohol Dependence, 142, 46-55. DOI Scopus8 WoS9 Europe PMC7 |
2014 |
Marsden, J., Eastwood, B., Ali, R., Burkinshaw, P., Chohan, G., Copello, A., . . . Day, E. (2014). Development of the Addiction Dimensions for Assessment and Personalised Treatment (ADAPT). Drug and Alcohol Dependence, 139, 121-131. DOI Scopus20 WoS19 Europe PMC7 |
2014 |
Larance, B., Lintzeris, N., Ali, R., Dietze, P., Mattick, R., Jenkinson, R., . . . Degenhardt, L. (2014). The diversion and injection of a buprenorphine-naloxone soluble film formulation. Drug and Alcohol Dependence, 136(1), 21-27. DOI Scopus40 WoS36 Europe PMC21 |
2014 |
Marshall, K., Gowing, L., Ali, R., & Le Foll, B. (2014). Pharmacotherapies for cannabis dependence. The Cochrane database of systematic reviews, 12(12), CD008940. DOI Scopus94 WoS70 Europe PMC25 |
2014 |
Gowing, L., Farrell, M., Ali, R., & White, J. (2014). Alpha2-adrenergic agonists for the management of opioid withdrawal (review). The Cochrane database of systematic reviews, 2014(3), CD002024-1-CD002024-87. DOI Scopus71 WoS21 Europe PMC20 |
2014 |
Somogyi, A., Barratt, D., Ali, R., & Coller, J. (2014). Pharmacogenomics of methadone maintenance treatment. Pharmacogenomics, 15(7), 1007-1027. DOI Scopus33 WoS31 Europe PMC24 |
2014 |
Alho, H., Fischer, G., Torrens, M., Maremmani, I., Ali, R., & Clark, N. (2014). Guidelines in the treatment of opiate addiction: a review and recommendation. Heroin Addiction and Related Clinical Problems, 16(4), 33-39. Scopus3 WoS4 |
2013 |
Ali, R., Meena, S., Eastwood, B., Richards, I., & Marsden, J. (2013). Ultra-rapid screening for substance-use disorders: The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST-Lite). Drug and Alcohol Dependence, 132(1-2), 352-361. DOI Scopus60 WoS56 Europe PMC36 |
2013 |
Hotham, E., Ali, R., White, J., Sullivan, T., & Robinson, J. (2013). Investigation of the Alcohol, Smoking, and Substance Involvement Screening Test (the ASSIST) Version 3.0 in pregnancy. Addictive Disorders & Their Treatment, 12(3), 123-135. DOI Scopus5 |
2013 |
Amato, L., Davoli, M., Minozzi, S., Ferroni, E., Ali, R., & Ferri, M. (2013). Methadone at tapered doses for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, 2(2), 1-68. DOI Scopus56 WoS60 Europe PMC33 |
2013 |
McKetin, R., Lubman, D., Baker, A., Dawe, S., & Ali, R. (2013). Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study. JAMA Psychiatry, 70(3), 319-324. DOI Scopus130 WoS122 Europe PMC64 |
2013 |
Lintzeris, N., Leung, S., Dunlop, A., Larance, B., White, N., Rivas, G., . . . Ali, R. (2013). A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence. Drug and Alcohol Dependence, 131(1-2), 119-126. DOI Scopus36 WoS33 Europe PMC20 |
2012 |
McKetin, R., Najman, J., Baker, A., Lubman, D., Dawe, S., Ali, R., . . . Mamun, A. (2012). Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES). Addiction, 107(11), 1998-2008. DOI Scopus90 WoS89 Europe PMC52 |
2012 |
Hotham, E., White, J., Ali, R., & Robinson, J. (2012). Screening for use of alcohol, tobacco and cannabis in pregnancy using self-report tools. Journal of Developmental Origins of Health and Disease, 3(4), 216-223. DOI Scopus1 |
2012 |
Vuong, T., Ali, R., Baldwin, S., & Mills, S. (2012). Drug policy in Vietnam: a decade of change?. International Journal of Drug Policy, 23(4), 319-326. DOI Scopus37 WoS35 Europe PMC20 |
2012 |
Humeniuk, R., Ali, R., Babor, T., Formigoni, M., Boerngen de Lacerda, R., Ling, W., . . . Vendetti, J. (2012). A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries. Addiction, 107(5), 957-966. DOI Scopus142 WoS133 Europe PMC103 |
2012 |
Sarasvita, R., Tonkin, A., Utomo, B., & Ali, R. (2012). Predictive factors for treatment retention in methadone programs in Indonesia. Journal of Substance Abuse Treatment, 42(3), 239-246. DOI Scopus49 WoS46 Europe PMC36 |
2011 |
Amato, L., Davoli, M., Vecchi, S., Ali, R., Farrell, M., Faggiano, F., . . . Chengzheng, Z. (2011). Cochrane systematic reviews in the field of addiction: what's there and what should be. Drug and Alcohol Dependence, 113(2-3), 96-113. DOI Scopus19 WoS18 Europe PMC8 |
2011 |
Larance, B., Degenhardt, L., O'Brien, S., Lintzeris, N., Winstock, A., Mattick, R., . . . Ali, R. (2011). Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients. Drug and Alcohol Review, 30(6), 613-620. DOI Scopus18 WoS15 Europe PMC9 |
2011 |
Larance, B., Degenhardt, L., Lintzeris, N., Bell, J., Winstock, A., Dietze, P., . . . Horyniak, D. (2011). Post-marketing surveillance of buprenorphine-naloxone in Australia: Diversion, injection and adherence with supervised dosing. Drug and Alcohol Dependence, 118(2-3), 265-273. DOI Scopus60 WoS57 Europe PMC33 |
2011 |
Gowing, L., Farrell, M., Bornemann, R., Sullivan, L., & Ali, R. (2011). Oral substitution treatment of injecting opioid users for prevention of HIV infection (Review). The Cochrane Database of Systematic Reviews, (8), 004145-1-004145-116. DOI Scopus195 WoS194 Europe PMC92 |
2011 |
Srisurapanont, M., Arunpongpaisal, S., Wada, K., Marsden, J., Ali, R., & Kongsakon, R. (2011). Comparisons of methamphetamine psychotic and schizophrenic symptoms: A differential item functioning analysis. Progress in Neuro-psychopharmacology & Biological Psychiatry, 35(4), 959-964. DOI Scopus66 WoS55 Europe PMC35 |
2011 |
Black, E., Larance, B., Mattick, R., Lintzeris, N., Degenhardt, L., Bruno, R., . . . Holland, R. (2011). MINIMISING THE UNINTENDED CONSEQUENCES OF OPIOID TREATMENT: DEVELOPMENT OF A DRUG BEHAVIOUR SCALE FOR USE IN AUSTRALIA. DRUG AND ALCOHOL REVIEW, 30, 11. |
2011 |
Marshall, K., Gowing, L., & Ali, R. (2011). Pharmacotherapies for cannabis withdrawal. Cochrane Database of Systematic Reviews, (1), 008940-1-008940-11. DOI |
2010 |
Ali, R., Marsden, J., Srisurapanont, M., Sunga, A., Baigent, M., & Monteiro, M. (2010). Methamphetamine psychosis in Australia, Philippines, and Thailand: Recommendations for acute care and clinical inpatient management. Addictive Disorders & Their Treatment, 9(4), 143-149. DOI Scopus9 |
2010 |
Tomas-Rossello, J., Rawson, R., Zarza, M., Bellows, A., Busse, A., Saenz, E., . . . Ling, W. (2010). United Nations Office on Drugs and Crime International Network of Drug Dependence Treatment and Rehabilitation Resource Centres: Treatnet. Substance Abuse, 31(4), 251-263. DOI Scopus14 WoS10 Europe PMC6 |
2010 |
Kettler, L., Nikic, M., Newcombe, D., & Ali, R. (2010). Mood disturbance and withdrawal severity in substitution treatment for opioid dependence: Their association and impact on continued illicit drug use. Addictive Disorders & Their Treatment, 9(1), 1-7. DOI |
2010 |
Poznyak, V., Ali, R., Meena, S., & Du, J. (2010). Substance involvement screening test (assist) symposium. Drug and Alcohol Review, 29(Suppl 1), 59. |
2010 |
Hotham, E., Ali, R., White, J., & Robinson, J. (2010). The alcohol, smoking and substance involvement screening test (the assist) version 3.0 in pregnancy. Drug and Alcohol Review, 29(Suppl 1), 35. |
2010 |
Edson, M., Ali, R., & Buisman-Pijlman, F. (2010). Can recent advances in prevention and treatment of occupational blood-born enfections bring NSP in prisons a step closer. Drug and Alcohol Review, 29(Suppl 1), 25. |
2010 |
Gowing, L., Ali, R., & White, J. (2010). Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. The Cochrane Database of Systematic Reviews, (1), 28 pages. DOI Scopus23 WoS4 |
2009 |
Gowing, L., Ali, R., & White, J. (2009). Opioid antagonists with minimal sedation for opioid withdrawal. The Cochrane Database of Systematic Reviews, 2009(4), 1-47. DOI Scopus26 WoS20 Europe PMC11 |
2009 |
Degenhardt, L., Larance, B., Bell, J., Winstock, A., Lintzeris, N., Ali, R., . . . Mattick, R. (2009). Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation. Medical Journal of Australia, 191(3), 161-165. DOI Scopus41 WoS41 Europe PMC18 |
2009 |
Gowing, L., Ali, R., & White, J. (2009). Buprenorphine for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, 2009(3), 1-76. DOI Scopus145 WoS72 Europe PMC34 |
2009 |
Gowing, L., Farrell, M., Ali, R., & White, J. (2009). Alpha₂-adrenergic agonists for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, Online(2), 1-87. DOI Scopus83 WoS43 Europe PMC17 |
2009 |
Lintzeris, N., Ali, R., Dunlop, A., Haber, P., & Wodak, A. (2009). PRESCRIPTION OPIOID POLICY: WHAT IS WORKING, NOT WORKING, AND WHAT CAN WE DO BETTER. DRUG AND ALCOHOL REVIEW, 28, A75. |
2009 |
Gowing, L., Ali, R., & White, J. M. (2009). Buprenorphine for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (3), 38 pages. DOI Scopus31 WoS40 Europe PMC15 |
2009 |
Ali, R., Burrows, D., Gowing, L., Vial, R., Walsh, N., Onyancha, P., & Finnerty, E. (2009). Review of Global Policy Architecture and Country Level Practice on HIV/AIDS and Drug Treatment. |
2009 |
Mcketin, R., Ross, J., Najman, J., Baker, A., Lubman, D., Dawe, S., . . . Mamun, A. (2009). TREATMENT OUTCOMES FOR METHAMPHETAMINE USE: FINDING FROM THE METHAMPHETAMINE TREATMENT EVALUATION STUDY (MATES). DRUG AND ALCOHOL REVIEW, 28, A76-A77. |
2008 |
Humeniuk, R., Ali, R., Babor, T., Farrell, M., Formigoni, M., Jittiwutikarn, J., . . . Simon, S. (2008). Validation of the alcohol, smoking and substance involement screening test (ASSIST). Addiction, 103(6), 1039-1047. DOI Scopus589 WoS566 Europe PMC440 |
2008 |
Gibson, A., Degenhardt, L., Mattick, R., Ali, R., White, J., & O'Brien, S. (2008). Exposure to opioid maintenance treatment reduces long-term mortality. Addiction, 103(3), 462-468. DOI Scopus138 WoS127 Europe PMC89 |
2008 |
Gowing, L., Farrell, M., Bornemann, R., Sullivan, L., & Ali, R. (2008). Substitution treatment of injecting opioid users for prevention of HIV infection. The Cochrane Database of Systematic Reviews, 2009(2), 1-102. DOI Scopus202 WoS124 Europe PMC37 |
2008 |
Somogyi, A., Larsen, M., Abadi, R., Jittiwutikarn, J., Ali, R., & White, J. (2008). Flexible dosing of Tincture of Opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics. British Journal of Clinical Pharmacology, 66(5), 640-647. DOI Scopus16 WoS17 Europe PMC12 |
2008 |
Lawrinson, P., Ali, R., Buarvirat, A., Chiamwongpaet, S., Dvoryak, S., Habrat, B., . . . Zhao, C. (2008). Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction, 103(9), 1484-1492. DOI Scopus171 WoS164 Europe PMC123 |
2008 |
Hotham, E., Ali, R., White, J., & Robinson, J. (2008). Pregnancy-related changes in tobacco, alcohol and cannabis use reported by antenatal patients at two public hospitals in South Australia. Australian & New Zealand Journal of Obstetrics & Gynaecology, 48(3), 248-254. DOI Scopus34 WoS30 Europe PMC16 |
2008 |
Wodak, A., Ali, R., Sansom, L., & Henry, D. (2008). Ensuring the safety of new medications and devices: are naltrexone implants safe?. Medical Journal of Australia, 188(8), 438-439. DOI Scopus9 WoS8 Europe PMC2 |
2008 |
McKetin, R., Kozel, N., Douglas, J., Ali, R., Vicknasingam, B., Lund, J., & Li, J. (2008). The rise of methamphetamine in southeast and East Asia. Drug and Alcohol Review, 27(3), 220-228. DOI Scopus114 WoS103 Europe PMC74 |
2006 |
O'Brien, S., Mattick, R., White, J., Breen, C., Kimber, J., Ritter, A., & Lintzeris, N. (2006). Maintenance pharmacotherapy for opioid dependence and SF-36 Health status: a comparison with general population norms and other chronic disorders. Addictive Disorders & Their Treatment, 5(4), 155-164. DOI Scopus13 |
2006 |
Teesson, M., Ross, J., Darke, S., Lynskey, M., Ali, R., Ritter, A., & Cooke, R. (2006). One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Dependence, 83(2), 174-180. DOI Scopus112 WoS104 Europe PMC60 |
2006 |
Gowing, L., Ali, R., & White, J. (2006). Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal (review). The Cochrane Database of Systematic Reviews, Online(Issue 2. Art. No. CD002022), 1-26. DOI Scopus40 WoS38 Europe PMC12 |
2006 |
Kornor, H., Waal, H., & Ali, R. (2006). Abstinence-orientated buprenorphine replacement therapy for young adults in out-patient counselling. Drug and Alcohol Review, 25(2), 123-130. DOI Scopus10 WoS10 Europe PMC6 |
2006 |
Gowing, L., & Ali, R. (2006). The place of detoxification in treatment of opioid dependence. Current Opinion in Psychiatry, 19(3), 266-270. DOI Scopus23 WoS15 Europe PMC11 |
2006 |
Gowing, L., Ali, R., & White, J. (2006). Opioid antagonists with minimal sedation for opioid withdrawal (review). The Cochrane Database of Systematic Reviews, Online(1AR CD002021DI ARTN CD002021), 2021. DOI Scopus14 WoS4 Europe PMC3 |
2006 |
Gowing, L., Farrell, M., Bornemann, R., Sullivan, L., & Ali, R. (2006). Methadone treatment of injecting opioid users for prevention of HIV infection. Journal of General Internal Medicine (online), 21(2), 193-195. DOI Scopus81 WoS73 Europe PMC48 |
2006 |
Shanahan, M., Doran, C., Digiusto, E., Bell, J., Lintzeris, N., White, J., . . . Gilmour, S. (2006). A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Addictive Behaviors, 31(3), 371-387. DOI Scopus21 WoS17 Europe PMC12 |
2006 |
Ross, J., Teesson, M., Darke, S., Lynskey, M., Ali, R., Ritter, A., & Cooke, R. (2006). Short-term outcomes for the treatment of heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). Addictive Disorders and their Treatment, 5(3), 133-143. DOI Scopus24 |
2005 |
Amato, L., Davoli, M., Minozzi, S., Ali, R., & Ferri, M. (2005). Methadone at tapered doses for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (3), 34 pages. DOI Scopus59 WoS39 Europe PMC20 |
2005 |
Humeniuk, R., & Ali, R. (2005). The first methadone clinic in Beijing. Drug and Alcohol Review, 24(3), 285-287. DOI Scopus6 WoS5 Europe PMC5 |
2005 |
Reece, A. S. (2005). HIV in injecting drug users in Asian countries: naltrexone implants are set to supersede harm minimisation.. BMJ (Clinical research ed.), 330(7483), 147. DOI |
2005 |
Wodak, A., Ali, R., & Farrell, M. (2005). HIV in injecting drug users in Asian countries - Reply. British Medical Journal, 330(7483), 147. DOI |
2005 |
Ross, J., Teesson, M., Darke, S., Lynskey, M., Ali, R., Ritter, A., & Cooke, R. (2005). The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Review, 24(5), 411-418. DOI Scopus198 WoS193 Europe PMC115 |
2005 |
Darke, S., Ross, J., Teesson, M., Ali, R., Cooke, R., Ritter, A., & Lynskey, M. (2005). Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS). Journal of Substance Abuse Treatment, 28(3), 255-263. DOI Scopus82 WoS73 Europe PMC44 |
2005 |
Digiusto, E., Lintzeris, N., Breen, C., Kimber, J., Mattick, R., Bell, J., . . . Saunders, J. (2005). Short-term outcomes of five heroin detoxification methods in the Australian NEPOD project. Addictive Behaviors, 30(3), 443-456. DOI Scopus17 WoS17 Europe PMC13 |
2005 |
Farrell, M., Gowing, L., Marsden, J., Ling, W., & Ali, R. (2005). Effectiveness of drug dependence treatment in HIV prevention. International Journal of Drug Policy, 16S(SUPPL. 1), S67-S75. DOI Scopus53 WoS53 |
2005 |
Newcombe, D., Humeniuk, R., & Ali, R. (2005). Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site. Drug and Alcohol Review, 24(3), 217-226. DOI Scopus177 WoS168 Europe PMC121 |
2004 |
Ling, W., Farrell, M., & Ali, R. (2004). Cochrane systematic reviews: time for an introduction and appraisal. Drug and Alcohol Dependence, 73(3), 217-218. DOI Scopus6 WoS6 Europe PMC5 |
2004 |
Jittiwutikarn, J., Ali, R., White, J., Bochner, F., Somogyi, A., & Foster, D. (2004). Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre. British Journal of Clinical Pharmacology, 58(5), 536-541. DOI Scopus15 WoS12 Europe PMC9 |
2004 |
Wodak, A., Ali, R., & Farrell, M. (2004). HIV in injecting drug users in Asian countries. British Medical Journal, 329(7468), 697-698. DOI Scopus12 WoS7 Europe PMC7 |
2004 |
Gowing, L., Farrell, M., Ali, R., & White, J. (2004). Alpha2 adrenergic agonists for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online : Update Software), (4), 45 pages. DOI Scopus28 WoS9 Europe PMC9 |
2004 |
Kaya, C. Y., Tugai, Y., Filar, J. A., Agrawal, M. R., Ali, R. L., Gowing, L. R., & Cooke, R. (2004). Heroin users in Australia: population trends. Drug and Alcohol Review, 23(1), 107-116. DOI Scopus13 WoS9 Europe PMC1 |
2004 |
Gowing, L., Ali, R., & White, J. (2004). Buprenorphine for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (4), CD002025. DOI Scopus35 Europe PMC4 |
2004 |
Gowing, L., Farrell, M., Bornemann, R., & Ali, R. (2004). Substitution treatment of injecting opioid users for prevention of HIV infection.. Cochrane database of systematic reviews (Online), (4), CD004145. DOI Scopus34 Europe PMC7 |
2004 |
Humeniuk, R., & Ali, R. (2004). Amphetamines in Asia: the value of information networks. Drug and Alcohol Review, 23(2), 235-237. DOI Scopus2 |
2004 |
Longo, M. C., Henry-Edwards, S. M., Humeniuk, R. E., Christie, P., & Ali, R. L. (2004). Impact of the heroin 'drought' on patterns of drug use and drug-related harms. Drug and Alcohol Review, 23(2), 143-150. DOI Scopus23 WoS22 Europe PMC13 |
2004 |
Humeniuk, R., Ali, R., & Ling, W. (2004). Substance use and treatment options in Cambodia. Drug and Alcohol Review, 23(3), 365-367. DOI Scopus2 WoS2 Europe PMC2 |
2004 |
Amato, L., Davoli, M., Minozzi, S., Ali, R., & Ferri, M. (2004). Methadone at tapered doses for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (3), CD003409. DOI Europe PMC3 |
2004 |
Humeniuk, R., & Ali, R. (2004). Asia Pacific Column. Announcement of column on capacity building in the Asia Pacific region.. Drug and alcohol review, 23(1), 133-134. DOI |
2003 |
Gowing, L., Farrell, M., Ali, R., & White, J. (2003). Alpha2 adrenergic agonists for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (2), CD002024. DOI Scopus6 Europe PMC2 |
2003 |
Amato, L., Davoli, M., Ferri, M., & Ali, R. (2003). Methadone at tapered doses for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (1), CD003409. DOI Scopus93 Europe PMC1 |
2003 |
Srisurapanont, M., Ali, R., Marsden, J., Sunga, A., Wada, K., & Monteiro, M. (2003). Psychotic symptoms in methamphetamine psychotic in-patients. International Journal of Neuropsychopharmacology, 6(4), 347-352. DOI Scopus130 WoS114 Europe PMC69 |
2003 |
Humeniuk, R., Ali, R., McGregor, C., & Darke, S. (2003). Prevalence and correlates of intravenous methadone syrup administration in Adelaide, Australia. Addiction, 98(4), 413-418. DOI Scopus40 WoS37 Europe PMC26 |
2003 |
Ali, R., Thomas, P., White, J., McGregor, C., Danz, C., Gowing, L., . . . Athanasos, P. (2003). Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: determinants of withdrawal severity. Drug and Alcohol Review, 22(4), 425-431. DOI Scopus9 WoS9 Europe PMC6 |
2003 |
Mattick, R., Ali, R., White, J., O'Brien, S., Wolk, S., & Danz, C. (2003). Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction, 98(4), 441-452. DOI Scopus224 WoS198 Europe PMC138 |
2003 |
Doran, C., Shanahan, M., Mattick, R., Ali, R., White, J., & Bell, J. (2003). Buprenorphine versus methadone maintenance: a cost-effectiveness analysis. Drug and Alcohol Dependence, 71(3), 295-302. DOI Scopus91 WoS77 Europe PMC65 |
2002 |
Doverty, M., White, J., Somogyi, A., Bochner, F., Ali, R., & Ling, W. (2002). Reply to Dr. Clark's comment on Doverty et al., hyperalgesic responses in methadone maintenance patients (Pain 2001;90 : 91-96). Pain, 99(3), 609-610. DOI WoS1 |
2002 |
Farrell, M., Marsden, J., Ali, R., & Ling, W. (2002). Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region. Addiction, 97(7), 771-772. DOI Scopus98 WoS88 Europe PMC59 |
2002 |
Gowing, L., Henry-Edwards, S., Irvine, R., & Ali, R. (2002). The health effects of ecstacy: a literature review. Drug and Alcohol Review, 21(1), 53-63. DOI Scopus119 Europe PMC71 |
2002 |
Gowing, L., Ali, R., & White, J. (2002). Which substitution pharmacotherapy is most effective in treating opioid dependence?. Medical Journal of Australia, 176(10), 493-494. DOI |
2002 |
Ali, R., Awwad, E., Babor, T., Bradley, F., Butau, T., Farrell, M., . . . Vendetti, J. (2002). The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction, 97(9), 1183-1194. DOI Scopus996 WoS921 Europe PMC649 |
2002 |
White, J., Danz, C., Kneebone, J., La Vincente, S., Newcombe, D., & Ali, R. (2002). Relationship between LAAM-methadone preference and treatment outcomes. Drug and Alcohol Dependence, 66(3), 295-301. DOI Scopus18 WoS16 Europe PMC10 |
2002 |
Gowing, L., Farrell, M., Ali, R., & White, J. (2002). a₂-Adrenergic agonists in opioid withdrawal. Addiction, 97(1), 49-58. DOI Scopus60 WoS47 Europe PMC45 |
2002 |
McGregor, C., Ali, R., Lokan, R., Christie, P., & Darke, S. (2002). Accidental fatalities among heroin users in South Australia, 1994-1997: Toxicological findings and circumstances of death. Addiction Research and Theory, 10(4), 335-346. DOI Scopus22 WoS14 |
2002 |
McGregor, C., Ali, R., White, J., Thomas, P., & Gowing, L. (2002). A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months. Drug and Alcohol Dependence, 68(1), 5-14. DOI Scopus35 WoS34 Europe PMC23 |
2002 |
Gowing, L., Ali, R., & White, J. (2002). Buprenorphine for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, (2), CD002025-1-CD002025-22. DOI Scopus19 Europe PMC4 |
2002 |
Gowing, L., Ali, R., & White, J. (2002). Buprenorphine for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (2), CD002025. DOI Scopus28 Europe PMC7 |
2002 |
Gowing, L., Ali, R., & White, J. (2002). Opioid antagonists with minimal sedation for opioid withdrawal.. Cochrane database of systematic reviews (Online : Update Software), (2), CD002021. DOI Scopus14 Europe PMC3 |
2002 |
Gowing, L. R., Henry-Edwards, S. M., Irvine, R. J., & Ali, R. L. (2002). The health effects of ecstasy: a literature review. DRUG AND ALCOHOL REVIEW, 21(1), 53-63. DOI WoS97 |
2002 |
Gowing, L., Ali, R., & White, J. (2002). Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal.. Cochrane database of systematic reviews (Online), (2), CD002022. DOI Scopus16 Europe PMC4 |
2002 |
Bammer, G., Hall, W., Hamilton, M., & Ali, R. (2002). Harm minimization in a prohibition context - Australia. Annals of the American Academy of Political and Social Science, 582(JULY), 80-93. DOI Scopus13 WoS11 |
2002 |
Amato, L., Davoli, M., Ferri, M., & Ali, R. (2002). Methadone at tapered doses for the management of opioid withdrawal.. The Cochrane database of systematic reviews, (1), CD003409. DOI Europe PMC1 |
2002 |
Amato, L., Davoli, M., Ferri, M., & Ali, R. (2002). Methadone at tapered doses for the management of opioid withdrawal.. Cochrane Database Syst Rev, (1), CD003409. DOI |
2001 |
McGregor, C., Ali, R., Christie, P., & Darke, S. (2001). Overdose among heroin users: Evaluation of an intervention in South Australia. Addiction Research and Theory, 9(5), 481-501. DOI Scopus17 WoS16 |
2001 |
Gowing, L., Ali, R., & White, J. (2001). Buprenorphine for the management of opioid withdrawal. Praxis, 90(44), 1934. |
2001 |
Mattick, R., Ali, R., Auriacombe, M., Davoli, M., Faggiano, F., Farrell, M., . . . Ling, W. (2001). Cochrane drugs and alcohol group: The development of systematic reviews of treatment outcome. Alcohol and Alcoholism, 36(2), 109-111. DOI Scopus3 WoS1 Europe PMC1 |
2001 |
Gowing, L., Farrell, M., Ali, R., & White, J. (2001). Alpha2 adrenergic agonists for the management of opioid withdrawal.. Cochrane database of systematic reviews (Online), (1), CD002024. DOI Scopus18 Europe PMC5 |
2001 |
Gowing, L., Ali, R., & White, J. (2001). Opioid antagonists under sedation or anaesthesia for opioid withdrawal.. Cochrane database of systematic reviews (Online), (1), CD002022. DOI Scopus11 Europe PMC1 |
2001 |
Doverty, M., White, J., Somogyi, A., Bochner, F., Ali, R., & Ling, W. (2001). Hyperalgesic responses in methadone maintenance patients. Pain, 90(01-Feb), 91-96. DOI Scopus234 WoS200 Europe PMC151 |
2000 |
Gowing, L., Ali, R., & White, J. (2000). Opioid antagonists and adrenergic agonists for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, (2), 1-2. DOI Scopus15 Europe PMC4 |
2000 |
Gowing, L., Ali, R., & White, J. (2000). The management of opioid withdrawal. Drug and Alcohol Review, 19(3), 309-318. DOI Scopus16 WoS14 |
2000 |
Gowing, L., Ali, R., & White, J. (2000). Systematic review processes and the management of opioid withdrawal. Australian and New Zealand Journal of Public Health, 24(4), 427-431. DOI Scopus5 WoS3 Europe PMC3 |
2000 |
Single, E., Christie, P., & Ali, R. (2000). The impact of cannabis decriminalisation in australia and the united states. Journal of Public Health Policy, 21(2), 157-186. DOI Scopus66 WoS52 Europe PMC18 |
2000 |
Gowing, L., Ali, R., & White, J. (2000). Opioid antagonists and adrenergic agonists for the management of opioid withdrawal. Praxis, 89(44), 1810-1811. |
2000 |
Ali, R., McGregor, C., Christie, P., & Darke, S. (2000). Heroin overdose: Responding to the epidemic. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 34(s1), A1-A2. DOI WoS1 |
2000 |
Christie, P., & Ali, R. (2000). Offences under the Cannabis Expiation Notice scheme in South Australia. Drug and Alcohol Review, 19(3), 251-256. DOI Scopus16 WoS13 |
2000 |
Allsop, S. J., Ali, R. L., & Edmonds, C. A. (2000). A training, authorisation and review process for methadone prescribers. Journal of Maintenance in the Addictions, 1(4), 15-25. DOI Scopus2 |
2000 |
Ali, R. (2000). Special section: Cannabis expiation in South Australia - Introduction. DRUG AND ALCOHOL REVIEW, 19(3), 249. WoS2 |
1999 |
Ali, R., Auriacombe, M., Casas, M., Cottler, L., Farrell, M., Kleiber, D., . . . Ward, P. (1999). Report of the external panel on the evaluation of the Swiss scientific studies of medically prescribed narcotics to drug addicts. Sucht, 45(3), 160-170. Scopus21 |
1999 |
Ali, R. L., & Quigley, A. J. (1999). Accidental drug toxicity associated with methadone maintenance treatment. Medical Journal of Australia, 170(3), 100-101. DOI Scopus5 WoS5 Europe PMC2 |
1999 |
Lenton, S., McDonald, D., Ali, R., & Moore, T. (1999). Laws applying to minor cannabis offences in Australia and their evaluation. International Journal of Drug Policy, 10(4), 299-303. DOI Scopus3 |
1999 |
Vincent, N., Shoobridge, J. A., Ask, A., Allsop, S., & Ali, R. (1999). Characteristics of amphetamine users seeking information, help and treatment in Adelaide, South Australia. Drug and Alcohol Review, 18(1), 63-73. |
1999 |
Vincent, N., Shoobridge, J., Ask, A., Allsop, S., & Ali, R. (1999). Characteristics of amphetamine users seeking information, help and treatment in Adelaide, South Australia.. Drug and Alcohol Review, 18(1), 63-73. DOI Scopus19 WoS17 |
1999 |
Wolff, K., Farrell, M., Marsden, J., Monteiro, M., Ali, R., Welch, S., & Strang, J. (1999). A review of biological indicators of illicit drug use, practical considerations and clinical usefulness.. Addiction, 94(9), 1279-1298. DOI Scopus144 WoS126 Europe PMC83 |
1998 |
Gaughwin, M., Solomon, P., & Ali, R. (1998). Correlates of retention on the South Australian methadone program 1981-91. Australian New Zealand Journal of Public Health, 22(7), 771-776. DOI Scopus11 WoS10 Europe PMC6 |
1998 |
Gowing, L., Ali, R., Christie, P., & White, J. (1998). Therapeutic use of cannabis: clarifying the debate. Drug and Alcohol Review, 17(4), 445-452. DOI WoS2 Europe PMC1 |
1998 |
Vincent, N., Shoobridge, J., Ask, A., Allsop, S., & Ali, R. (1998). Physical and mental health problems in amphetamine users from metropolitan Adelaide, Australia. Drug and Alcohol Review, 17(2), 187-195. DOI Scopus27 WoS26 Europe PMC15 |
1998 |
Mcgregor, C., Darke, S., Ali, R., & Christie, P. (1998). Experience of non-fatal overdose among heroin users in Adelaide, Australia: Circumstances and risk perceptions. Addiction, 93(5), 701-711. DOI Scopus178 WoS165 Europe PMC107 |
1997 |
MacDonald, M., Wodak, A. D., Ali, R., Crofts, N., Cunningham, P. H., Dolan, K. A., . . . Kaldor, J. M. (1997). HIV prevalence and risk behaviour in needle exchange attenders: A national study. Medical Journal of Australia, 166(5), 237-240. DOI Scopus63 WoS59 Europe PMC37 |
1997 |
Ali, R. (1997). America's drug war debacle. ADDICTION, 92(12), 1790-1791. |
1996 |
Strang, J., Darke, S., Hall, W., Farrell, M., & Ali, R. (1996). Heroin overdose: the case for take-home naltrexone. British Medical Journal, 312(7044), 1435-1436. DOI Scopus124 WoS114 Europe PMC72 |
1996 |
White, J., Ryan, C., & Ali, R. (1996). Improvements in retention rates and changes in client groups with methadone maintenance streaming.. Drug and Alcohol Review, 15(1), 83-88. DOI Scopus16 WoS14 Europe PMC9 |
1995 |
Gaughwin, M. D., & Ali, R. (1995). HIV infection among injecting drug users in the South Australian methadone program. Medical Journal of Australia, 162(5), 242-244. DOI Scopus6 WoS5 Europe PMC2 |
1994 |
Waddell, R. G., Gaughwin, M., Dodding, J., Ali, R., & Crofts, N. (1994). Hepatitis C and the history of injecting drug use in South Australia [3]. Medical Journal of Australia, 161(4), 286-287. DOI Scopus6 WoS7 Europe PMC1 |
1994 |
GAUGHWIN, M., DODDING, J., & ALI, R. (1994). HEPATITIS-C AND THE HISTORY OF INJECTING DRUG-USE IN SOUTH AUSTRALIA - REPLY. MEDICAL JOURNAL OF AUSTRALIA, 161(4), 286. DOI WoS7 Europe PMC1 |
1994 |
ALI, R. L., & CORMACK, S. M. (1994). In‐patient treatment for the alcohol‐dependent person: a public health perspective. Drug and Alcohol Review, 13(2), 195-202. DOI Scopus4 Europe PMC1 |
1994 |
White, J. M., Dyer, K. R., Ali, R. L., Gaughwin, M. D., & Cormack, S. (1994). Injecting behaviour and risky needle use amongst methadone maintenance clients. Drug and Alcohol Dependence, 34(2), 113-119. DOI Scopus11 WoS11 Europe PMC10 |
1993 |
Gaughwin, M., Kliewer, E., Ali, R., Faulkner, C., Wodak, A., & Anderson, G. (1993). The prescription of methadone for opiate dependence in Australia, 1985-1991. Medical Journal of Australia, 159(2), 107-108. DOI Scopus5 WoS5 Europe PMC3 |
1992 |
Weller, D. P., Litt, J. C. B., Pols, R. G., Ali, R. L., Southgate, D. O., & Harris, R. D. (1992). Drug and alcohol related health problems in primary care - What do GPs think?. Medical Journal of Australia, 156(1), 43-48. DOI Scopus58 WoS59 Europe PMC31 |
1991 |
Gaughwin, M., Douglas, R., Liew, C., Davies, L., Mylvaganam, A., Treffke, H., . . . Ali, R. (1991). HIV prevalence and risk behaviours for HIV transmission in South Australian prisons. AIDS, 5(7), 845-851. DOI Scopus42 WoS29 Europe PMC19 |
1991 |
Gaughwin, M., Gowans, E., Ali, R., & Burrell, C. (1991). Bloody needles: The volumes of blood transferred in simulations of needlestick injuries and shared use of syringes for injection of intravenous drugs. AIDS, 5(8), 1025-1027. DOI Scopus46 WoS51 Europe PMC27 |
1990 |
Gaughwin, M. D., Ryan, P., Treffke, H., Lee, M., & Ali, R. (1990). Can I buy a syringe? The availability of needles and syringes to intravenous drug users in Adelaide. Medical Journal of Australia, 153(9), 569. DOI Scopus1 WoS3 |
1990 |
Douglas, R. M., Gaugwhin, M. D., Ali, R. L., Davies, L. M., Mylvaganam, A., & Liew, C. Y. (1990). Risk of transmission of the human immunodeficiency virus in the prison setting. Medical Journal of Australia, 153(7), 434. DOI Europe PMC1 |
1990 |
Gaughwin, M., Douglas, R., Davies, L., Mylvaganam, A., Liew, C., & Ali, R. (1990). PREVENTING HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AMONG PRISONERS: PRISONERS' AND PRISON OFFICERS' KNOWLEDGE OF HIV AND THEIR ATTITUDES TO OPTIONS FOR PREVENTION. Community Health Studies, 14(1), 61-64. DOI Scopus1 WoS1 |
1989 |
Douglas, R. M., Gaughwin, M. D., Ali, R. L., Davies, L. M., Mylvaganam, A., & Liew, C. Y. (1989). Risk of transmission of the human immunodeficiency virus in the prison setting.. The Medical journal of Australia, 150(12), 722. DOI Scopus9 WoS7 Europe PMC1 |